Together with the piling evidence for the beneficial effects of TFEB upregulation found in neurons, promoting TFEB activity and lysosome biogenesis appears to be a general strategy to mitigate AD hallmarks in animal models [65,66]. The gene discussed is TFEB; the disease is Alzheimer disease.